tiprankstipranks
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (HK:2591)
:2591
Hong Kong Market
2591
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H
RESEARCH TOOLSreports
Want to see HK:2591 full AI Analyst Report?

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (2591) Income Statement

0 Followers

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Income Statement

Last quarter (Q4 2025), Guangzhou Innogen Pharmaceutical Group Co Ltd Class H's total revenue was ¥73.81M, an increase of 21.74% from previous quarter. In Q4, Guangzhou Innogen Pharmaceutical Group Co Ltd Class H's net income was ¥-215.24M. See Guangzhou Innogen Pharmaceutical Group Co Ltd Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23
Total Revenue
¥ 128.11M¥ 0.00¥ 0.00
Gross Profit
¥ 104.43M¥ 0.00¥ 0.00
Operating Expenses
¥ 438.33M¥ 189.41M¥ 746.84M
Depreciation and Amortization
¥ 9.60M¥ 16.92M¥ 19.64M
EBITDA
¥ -324.30M¥ -156.89M¥ -711.42M
Operating Income
¥ -333.90M¥ 0.00¥ 0.00
Other Income/Expenses
¥ 1.37M¥ -174.69M¥ -733.38M
Pretax Income
¥ -332.53M¥ -174.69M¥ -733.38M
Net Income
¥ -332.53M¥ -174.69M¥ -733.38M
Per Share Metrics
Basic EPS
¥ -0.76¥ -0.38¥ -1.61
Diluted EPS
¥ -0.76¥ -0.38¥ -1.61
Weighted Average Shares Outstanding
 434.08M 456.82M 456.82M
Weighted Average Shares Outstanding (Diluted)
 434.08M 456.82M 456.82M
Currency in CNY

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Earnings and Revenue History